Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response

Table 1 Patient characteristics

Patient	Gender/Age	Prior Therapies	Surgery^a	Histology	Tumor stage
1	F/78	none	upper bilobectomy	adenocarcinoma	IIIA
2	F/47	none	lobectomy	squamous-cell carcinoma	IB
3	M/65	none	lobectomy	large-cell carcinoma	IIA
4 ^b	M/77	none	lobectomy	adenocarcinoma	IB

ISSN: 1479-5876